National Regulator approves “Conditional Market Authorization” of two COVID19 Vaccines- Covaxin and Covishield

The National Regulator, Drugs Controller General of India (DCGI), has given nod to market authorization of two COVID19 vaccines, Covaxin and Covishield subject to certain conditions, here today. The Subject…

DCGI examining Zydus Cadila’s COVID vaccine for children, says Dr VK Paul

By Shalini Bhardwaj New Delhi [India], July 16 (ANI): Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health,…

Pfizer, Johnson and Johnson yet to apply for license of COVID-19 vaccines in India: Sources

New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and Johnson twice in writing to apply for emergency use authorisation for their…

DCGI’s expert panel to review Phase III data of Covaxin today

By Shalini Bhardwaj And Sahil Pandey New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat…

Bharat Biotech has submitted Covaxin’s Phase III trial data to DCGI: Govt sources

By Shalini Bhardwaj New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller…